Reagent Kit for Qualitative Detection of IgM Antibodies to SARS-CoV-2 Coronavirus (2019-nCoV IgM (CLIA)) in Serum or Plasma

Reagent Kit for Qualitative Detection of IgM Antibodies to SARS-CoV-2 Coronavirus (2019-nCoV IgM (CLIA)) in Serum or Plasma

Composition of the Kit:

• Reagent 1 (SARS-CoV-2 IgM CLIA Reagent 1) - 1 vial x 10 ml.
• Reagent 2 (SARS-CoV-2 IgM CLIA Reagent 2) - 1 vial x 10 ml.
• Reagent 3 (SARS-CoV-2 IgM CLIA Reagent 3) - 1 vial x 10 ml.
• Control Positive (SARS-CoV-2 IgM Control +) - 1 vial x 5 ml.
• Control Negative (SARS-CoV-2 IgM Control -) - 1 vial x 5 ml.
• Instructions for Use.

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagent Kit for Qualitative Detection of IgM Antibodies to SARS-CoV-2 Coronavirus (2019-nCoV IgM (CLIA)) in Serum or Plasma, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.